MBX Biosciences (MBX) Selling, General & Administrative (2023 - 2026)
MBX Biosciences (MBX) posted Selling, General & Administrative of $9.95 million for Q2 2026, up 143.7% from $4.08 million a year earlier and up 13.1% from the prior quarter.
Powered by 
Analysis
MBX Biosciences (MBX) Selling, General & Administrative (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at MBX Biosciences was $29.43 million, up 103.6% year-over-year; for FY2025, it came in at $18.9 million, up 75.3% from FY2024.
- In prior years, MBX Biosciences' Selling, General & Administrative was $10.78 million in FY2024 (+59.1%) and $6.78 million in FY2023.
- The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q3 2023.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last eight quarters, with growth averaging 82.8% over the last eight quarters.
- The year-over-year growth in Selling, General & Administrative has ranged between 49.6% (Q4 2024) and 143.7% (Q2 2026) over the last five years.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $8.79 million (Q1 2026), $6.04 million (Q4 2025) and $4.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 582.20 Mn |
| 10 | MBX Biosciences | 2.57 Bn | 2.57 Bn | - | 9.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.95 Mn |
| Mar 31, 2026 | 8.79 Mn |
| Dec 31, 2025 | 6.04 Mn |
| Sep 30, 2025 | 4.66 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Dec 31, 2024 | 3.39 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 2.26 Mn |
| Sep 30, 2023 | 1.87 Mn |
API Access
MBX Biosciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "MBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();